Skip to content Skip to footer
Insights+ Key Biosimilars Events of May 2024

Insights+ Key Biosimilars Events of May 2024

Shots:   Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency    Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and patients    During May, Teva & Alvotech launched Simlandi injection Treat Multiple Indications. Our…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]